The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2023 | Clinical efficacy and safety of CT-P10 in patients with DLBCL
Mark Bishton, MBChB, MRCP, FRCPath, PhD, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK, shares some insights into a study evaluating the real-world safety and efficacy of CT-P10 in patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Roche – conference travel, ad board
Takeda – educational meeting
Lilly – ad board
Celltrion – educational meetings
Incyte – ad board
